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Abstract 
   Herein, amphiphilic/fluorous random copolymers bearing poly(ethylene glycol) (PEG) chains 
and perfluorinated alkane pendants were developed as novel non-cytotoxic polymers for protein 
conjugation.  Three kinds of random copolymers with different initiating terminals (carboxylic 
acid, pyridyl disulfide, N-hydroxysuccinimide ester) were prepared by reversible 
addition-fragmentation chain transfer (RAFT) copolymerization of a PEG methyl ether 
methacrylate and a perfluorinated alkane methacrylate with corresponding functional chain transfer 
agents.  All of the polymers were soluble in water to form nanostructures with perfluorinated 
compartments via fluorous interaction: large aggregates from the intermolecular multi-chain 
association and compact unimer micelles from the intramolecular single-chain folding.  Such a 
PEGylated and perfluorinated random copolymer was non-cytotoxic to NIH 3T3 mouse embryonic 
fibroblast cells and human umbilical vein endothelial cells (HUVECs).  Additionally, a random 






   Biocompatible synthetic polymers often play important roles in creating new technologies and 
function for biomedical and biochemical applications with natural materials including proteins, 
genes, cells, and bacteria.1-8  Among them, proteins are one of the most widely used natural and 
functional biopolymers; they typically serve as therapeutic materials, as well as highly active and 
selective catalysts.  Such functions in proteins are derived from the inherent tertiary structures 
carrying specific inner cavities that are formed via the self-folding of the polymer chains in water 
with physical (hydrophobic, hydrogen-bonding, and ionic) interactions.  However, owing to the 
dynamic and labile conformation, proteins are often unstable and easy to denature via external 
stimuli (heat, desiccation, solvents, light, pH change, and lyophilization) and are typically rapidly 
cleaved by proteolytic enzymes and cleared from the body in vivo. 
   To enhance the stability for various applications, proteins have often been conjugated to 
poly(ethylene glycol) (PEG) and hydrophilic (or amphiphilic) polymers.9-22  In particular, 
controlled/living radical polymerization23-28 is a powerful tool to synthesize the latter polymers with 
desired properties and end-functionalization for such protein-polymer conjugates, since the 
polymerization system affords the direct and selective incorporation of polar functional groups and 
proteins into polymer segments (terminals and pendants) and the efficient control of precision 
primary structures and three-dimensional architectures of polymers.  Recently, several hydrophilic 
polymers including poly[poly(ethylene glycol) methyl ether methacrylate] (poly(PEGMA))10,13,15 
and trehalose glycopolymers11,12 have been successfully synthesized via reversible 
addition-fragmentation chain transfer (RAFT) polymerization25,26 for protein conjugation.  These 
synthetic polymers were non-cytotoxic12,29,30 and actually effective for the improvement of protein 
stability. 
   Amphiphilic copolymers potentially include additional advantages in protein conjugation and 
functionalization.  In contrast to hydrophilic homopolymers, amphiphilic random or block 
copolymers with water-insoluble segments efficiently provide globular polymeric nanomaterials 
(e.g., micelles, polymersomes, and nanogels) in water via the intermolecular association or 
intramolecular self-folding of their polymer chains.19,21,31-36  The globular objects could further 
confer the properties and functions resulting from these unique environments (on the surface and/or 
in the interior) to proteins.19,22 
   For biomedical applications, perfluorinated alkanes (fluorocarbons)37-42 are promising 
candidates as water-insoluble functional units for amphiphilic copolymers.  This is because 
perfluorinated compounds and polymers have several attractive features: the polymers are 
immiscible with both water and common organic solvents, yet have selective interactions with 
  
fluorinated compounds resulting in stable micellization, unique association, and molecular 
recognition;43-47 they also exhibit high sensitivity in 19F nuclear magnetic resonance (NMR),46-48 
high oxygen affinity,38,39 and biocompatibility (i.e. low acute toxicity, non cytotoxicity, and no 
hemolytic activity).38,49-51  Based on these features, fluorinated materials have been examined in 
biomedical research fields, typically as oxygen transport materials (blood substitutes) and drug 
delivery vessels.38,39  Thus, amphiphilic/fluorous copolymers bearing PEG chains and 
perfluorinated alkane units52 would not only stably form globular nanomaterials with fluorous 
confined spaces in water but may be also biocompatible, with low cytotoxicity and minimal protein 
denaturation; furthermore, the polymers would provide unique functions resulting from the 
perfluorinated compartments to proteins. 
      Given these possibilities, we developed amphiphilic/fluorous random copolymers with PEG 
chains and perfluorinated pendants as a new class of biocompatible polymeric materials for protein 
conjugation (Scheme 1).  The PEGylated and perfluorinated random copolymers (P1-P3) were 
synthesized by reversible addition-fragmentation chain transfer (RAFT) copolymerization.25,26  
Confirmed by 19F NMR spectroscopy and dynamic light scattering (DLS), their copolymers 
efficiently formed large aggregates with fluorous cores in water.  The cytotoxicity of the 
copolymer (P1) was examined with NIH 3T3 mouse embryonic fibroblast cells and human 
umbilical vein endothelial cells (HUVECs).  Additionally, a thiolated lysozyme was successfully 
conjugated to the fluorous core aggregate of the random copolymer carrying a pyridyl disulfide 
terminal (P2).  To our best knowledge, the example described herein, is the first to reveal the 
non-cytotoxicity of amphiphilic/fluorous copolymers obtained from living radical polymerization 




Scheme 1.  (a) Synthesis of amphiphilic/fluorous random copolymers (P1-P3) via reversible 
addition-fragmentation chain transfer (RAFT) copolymerization of PEGMA and 17FDeMA with 
CTA (1-3).  (b) Conjugation of a disulfide pyridine-bearing copolymer (P2) to a thiolated 







   Poly(ethylene glycol) methyl ether methacrylate (PEGMA: Aldrich, Mn ~ 500) and 
1H,1H,2H,2H-perfluorodecyl methacrylate (17FDeMA: Aldrich, purity ~ 97%) were used as 
received.  2,2’-Azobisisobutyronitrile (AIBN, Aldrich, purity ~ 99%) was recrystallized twice 
from ethanol and dried prior to use.  Toluene (Fischer Scientific, purity > 99%) was used as 
received.  Chain transfer agents (CTA: 1-3) were synthesized according to the previous 
literature.11  LIVE/DEAD® viability/cytotoxicity assay kit and CellTiter-Blue® cell viability 
assay were obtained from Invitrogen and Promega, respectively. 
  
Polymer Characterization 
   Number-average molecular weight (Mn) and Dispersity (Mw/Mn) of the polymers were measured 
by size exclusion chromatography (SEC) in DMF containing 10 mM LiBr at 40 oC (flow rate: 1 
mL/min) on three linear-type polystyrene gel columns (Shodex KF-805L: exclusion limit = 4 × 106; 
particle size = 10 m; pore size = 5000 Å; 0.8 cm i.d. × 30 cm) that were connected to a Jasco 
PU-2080 precision pump, a Jasco RI-2031 refractive index detector, and a Jasco UV-2075 UV/vis 
detector set at 270 nm.  The columns were calibrated against 10 standard samples of poly(methyl 
methacrylate) (Polymer Laboratories: Mn = 1000–1200000; Mw/Mn = 1.06–1.22).  1H and 19F 
NMR spectra were recorded in acetone-d6 or D2O at 25 oC on a JEOL JNM-ECA500 spectrometer, 
operating at 500.16 (1H), 470.62 (19F) MHz.  Dynamic light scattering (DLS) measurements were 
conduced to determine hydrodynamic radius (RH) on Otsuka Photal ELSZ-0 equipped with a 
semiconductor laser (λ = 658 nm) at 30 oC ([polymer] = 2.5 mg/mL in DMF).  The measuring 
angle was 165o, and the data were analyzed by CONTIN method.  Ultraviolet-visible absorption 
(UV-vis) spectroscopy was measured on a BioMate 5 (Thermospectronic) instrument. 
 
Polymer Synthesis 
   The synthesis of amphiphilic/fluorous random polymers was carried out by standard Schlenk 
technique with syringe under argon.  A typical procedure for P1 is as follows: 1 (5.9 mg, 0.028 
mmol), PEGMA (1.2 mL, 2.6 mmol), 17FDeMA (0.40 mL, 1.2 mmol) and 30 mM toluene stock 
solution of AIBN (0.47 mL, 0.014 mmol) were dissolved in toluene (3.8 mL) in a Schlenk tube.  
The tube was sealed and subjected to four freeze-pump-thaw cycles before immersion in a 70 °C oil 
bath.  After 4.5 h, the tube was immersed in liquid N2 to terminate the reaction.  The conversion 
of PEGMA and 17FDeMA was determined as 75% and 82%, respectively, by 1H NMR.  The 
product was precipitated into hexane and purified by dialysis against MeOH to give P1.  Mn 
(SEC) = 118000, Mw/Mn (SEC) = 2.10.  δH (500 MHz; acetone-d6; acetone) 4.5–4.2 (2H, br s, 
-COCH2CH2CF2), 4.2–4.0 (2H, br s, -COOCH2CH2O), 3.8–3.4 (4H, br s, -OCH2CH2O), 3.3 (3H, br 
s, -OCH3), 2.8–2.6 (2H, br s, -COCH2CH2CF2), 2.2–1.4 (2H, br s, -CH2-), 1.4–0.8 (3H, br s, 
-CCH3).  δF (470 MHz; acetone-d6; CF3COOH) -81.3 – -82.1 (3F, br s, -CF3), -113.3 – -114.6 (2F, 
br s, -CH2CF2-), -121.7 – -124.5 (10F, br s, -CF2-), -126.4 – -127.2 (2F, br s, -CF2CF3).  P2 and P3 
were similarly prepared and characterized. 
 
Terminal Transformation 
   The trithiocarbonate end group in P1 was transformed with AIBN before cytotoxic study.  P1 
(1070 mg, 0.020 mmol) and AIBN (99.7 mg, 0.61 mmol) were dissolved by toluene (6.2 mL) and 
DMF (3.7 mL) in a Schlenk tube.  The tube was degassed by three freeze-pump-thaw cycles and 
  
placed at 80 °C for 3 h.  After purified by dialysis against MeOH, the resulting P1 was analyzed 
by UV-vis: the absorption derived from the trithiocarbonate in P1 (λ = 309 nm) disappeared. 
 
Cytotoxicity Assay 
   The cell compatibility of P1 to NIH 3T3 mouse embryonic fibroblast cells (NIH 3T3, ATCC) 
and human umbilical vein endothelial cells (HUVECs, Promocell GmbH) was evaluated with a 
LIVE/DEAD viability/cytotoxicity assay (Invitrogen).  Controls were buffer only or media only.  
NIH 3T3 cells were cultured in Dulbecco's Modified Eagle Medium (DMEM; Gibco) supplemented 
with 10% fetal bovine serum (FBS) and 1% penicillin− streptomycin.  HUVECs were cultured in 
endothelial cell growth medium (Promocell) containing 2% FCS with supplements recommended 
by the supplier.  The cells were seeded in 48-well plates (BD Falcon) at a density of 6 × 103 cells 
per well.  After 24 h, culture media were replaced with 200 μL of the working medium containing 
known polymer concentrations of 0.1, 0.5, 1 mg/ mL or the control with buffer only.  After 
incubation for 48 h, the cells were gently washed twice with prewarmed Dulbecco's 
phosphate-buffered saline (D-PBS), and stained with the LIVE/DEAD reagent (2 μM calcein AM 
and 4 μM ethidium homodimer-1).  Fluorescent images of each well were captured on a Zeiss 
Axiovert 200 microscope with an AxioCam MRm camera and FluoArc mercury lamp.  The 
number of live and dead cells was counted; percent cell viability was calculated by dividing the 
number of live cells by the total number of cells.  All experiments were conducted with four 
repetitions.  The cell viability (%) was calculated with the following formula: 100 × (number of 
live cells/total number of cells).  The data is provided by normalizing each set to the control 
without any additives (media only). 
 
Statistical Analysis for Cell Viability Results 




      A thiolated lysozyme (Lyz-SH) was prepared according to the previous literature.11  To a 
1.5 mL Lo-Bind® centrifuge tube was added Lyz-SH (45.5 μL, 1.1 mg/mL, PBS: phosphate 
buffered solution, pH 7.4) and P2 (180 μL, 51.1 mg/mL in PBS, pH 7.4, 50 eq).  The total volume 
was thus 226 μL (PBS, pH 7.4).  The solution was stored at 4 °C for 24 h before characterization 




Results and Discussion 
 
Polymer Synthesis 
   Amphiphilic and fluorous random copolymers carrying poly(ethylene glycol) chains and 
perfluorinated alkane pendants (P1-P3) were synthesized by reversible addition-fragmentation 
chain transfer (RAFT) copolymerization of poly(ethylene glycol) methyl ether methacrylate 
(PEGMA) and 1H,1H,2H,2H-perfluorodecyl methacrylate (17FDeMA) with 
2,2’-azobis(isobutyronitrile) (AIBN) and chain transfer agents (CTAs, 1-3) in toluene at 70 oC.  
The three CTAs consist of trithiocarbonates with different functional groups: carboxylic acid (1); 
pyridyl disulfide (2); N-hydroxysuccinimide ester (3).  Both 2 and 3, obtained from 1, are designed 
for the conjugation of the resulting random copolymers onto a protein: the polymer from 2 (P2) can 
react with a thiol group-bearing protein to give the conjugate via a cleavable disulfide linkage, 
while that from 3 (P3) may react with amino groups on a protein to provide the conjugate via an 
amide bond.  The feed ratio of their monomers to CTAs (m = [PEGMA]0/[CTA]0, n = 
[17FDeMA]0/[CTA]0) was set as m/n = 70/30 (P1) and 60/40 (P2, P3). 
   In all cases, copolymerization smoothly and homogeneously proceeded up to 67% - 82% 
conversion in 4 or 4.5 hrs, giving amphiphilic/fluorous random copolymers (P1-P3) with high 
molecular weight [Mn = ~100000, Mw/Mn = 1.7-2.0, by size-exclusion chromatography (SEC) in 
DMF with poly(methyl methacrylate) calibration, Table 1].  The broad molecular weight 
distribution would be attributed to the suitability between the CTAs and methacrylate monomers.  
Analyzed by 1H NMR in acetone-d6, all of P1-P3 clearly exhibited proton signals originating from 
their polymer structures (Fig 1 and S1).  Typically, P1 showed methylene or methyl protons of 
poly(ethylene glycol) chains (c: 4.1 ppm, d: 3.8-3.7 ppm, e: 3.7-3.55 ppm, f: 3.55-3.4 ppm, g: 3.3 
ppm) and methylene protons of perfluorinated octane pendants (h: 4.4 ppm, i: 2.7 ppm), in addition 
to those of a methacrylate backbone (a: 2.2-1.4 ppm, b: 1.4-0.8 ppm) (Fig 1a).  The composition 
(molar ratio) of PEGMA and 17FDeMA was calculated from the area of their pendants (c/h): 
PEGMA/17FDeMA = 70/35 (P1), 60/48 (P2), 60/50 (P3).  More importantly, despite of broad 
molecular weight distribution, P2 showed small signals of the pyridyl end group at 8.5 – 6.5 ppm 
(Fig S1), indicating that pyridyl disulfide group was successfully introduced into P2 with 2.  In 
contrast, the N-hydroxysuccinimide end group of P3 was not observed owing to the overlap with 
the methylene groups of the polymer pendants. 
   P1-P3 further clearly exhibited 19F NMR signals assignable to their perfluorinated pendants in 
acetone-d6 [P1: -CF2- (A) –113, (B) –121- – 125, (C) –127 ppm; -CF3 (D) – 82 ppm, Fig 2a, Fig S2].  
To avoid undesirable cytotoxicity, the trithiocarbonate in the -end of P1 was removed by heating 
in the presence of AIBN (confirmed by UV-vis analysis, Fig S3).13 
  
Table 1. Synthesis of Amphiphilic/Fluorous Random Copolymersa 












P1 1 70 30 4.5 75/82 118000 2.10 70/35 15 (113) (6.2) 128 
P2 2 60 40 4 67/79 102000 1.71 60/48 13 (199) (21) 115 
P3 3 60 40 4 67/80 98300 1.79 60/50 13 (135) (15) 210 
a P1-P3 were synthesized by RAFT copolymerization of PEGMA and 17FDeMA with chain 
transfer agents (CTA: 1 - 3) and AIBN in toluene at 70 oC: [PEGMA]0/[17FDeMA]0/[CTA]0/ 
[AIBN]0 = 500/215/5/2.5 (P1), 430/285/5/2.5 (P2, P3),  m = [PEGMA]0/[CTA]0, n = 
[17FDeMA]0/[CTA]0. 
b Determined by SEC in DMF (10 mM LiBr) with PMMA standards. 
c Monomer composition (ratio) in copolymers: determined by 1H NMR. 
d Hydrodynamic radius (RH) in acetone or H2O, determined by DLS: [P1 - P3] = 10 mg/mL.  The 








Figure 2. 19F NMR spectra (470 MHz) of (a) P1 in acetone-d6, and (b) P1 and (c) P2 in D2O at 25 
oC. 
 
Folding and Association in Water 
   Owing to the hydrophilic PEG pendants, P1-P3 were soluble in water but would form 
self-folding unimer micelles and/or large multi-chain aggregates (or nanogel) via the fluorous 
interaction of the perfluorinated pendants.  Thus, P1-P3 were analyzed by dynamic light scattering 
(DLS) in acetone or H2O at 25 oC ([polymer] = 10 mg/mL).  In both solvents, all of the samples 
showed bimodal light scattering distribution (Fig 3), whereas the major portion of the size 
distribution (volume fraction) was dependent on the solvent.  Table 1 shows hydrodynamic radius 
(RH) corresponding to both major distribution and minor counterpart (the values in parentheses). 
   In acetone, P1-P3 mainly had small RH of 13 - 15 nm, indicating that most of P1-P3 exist as 
unimer in acetone.36  In water, P1-P3 in turn mainly showed DLS intensity distributions with large 
RH’s from 115 to 210 nm.  Thus, most of their polymers intermolecularly associate with multiple 
chains to form large aggregates in water.  In detail, the RH (6.2 nm) for the small size fraction of 
P1 (30 mol% 17FDeMA) in water was smaller than that for P1 unimer in acetone.  This suggests 
that a part of P1 self-folds in water to a compact unimer micelle.  Thus, P1 dynamically form both 
a self-folding structure and multi-chain aggregates in water. 
  
 
Figure 3.  DLS intensity distribution of (a) P1, (b) P2, and (c) P3 in acetone (dash) and H2O 
(solid) at 25 oC: [polymer]0 = 10 mg/mL. 
 
 
   To evaluate aggregation properties of their perfluorinated pendants in water, P1 and P2 were 
analyzed by 19F NMR in D2O at 25 oC (Fig 2b,c).  In both samples, the 19F signals (A-D) 
broadened, compared with those in acetone.  This importantly indicates that the self-folding and 
multi-chain association of the polymers in water are driven by the fluorous interaction of their 
perfluorinated pendants; both the unimer micelles and the large aggregates carry fluorinated inner 
cores covered by multiple short PEG chains (shell).  These structures were further supported by 1H 
NMR measurements of P1 and P2 in D2O (Fig 1b,c): methacrylate backbone proton signals (a,b), 
methylene protons adjacent to the backbones (c, h) and perfluorinated pendants (i) largely 
disappeared, while the PEG chain protons (e, f, g) were observed as sharp peaks. 
 
Cytotoxicity Study 
   To evaluate the potential biocompatibility of amphiphilic/fluorous random copolymers, 
cytotoxicity study of P1 was conducted with NIH 3T3 mouse embryonic fibroblast cells and human 
  
umbilical vein endothelial cells (HUVECs) (Fig 4).12  For this, NIH 3T3 and HUVECs were first 
respectively cultured in 48-well plates at density of 6000 cells per well for 24 h.  The culture 
media was then replaced with the working medium containing P1 at concentrations of 0.1, 0.5 and 
1.0 mg/mL.  After 48 h incubation, the cells were stained with the LIVE/DEAD regent, where live 
cells turn green and dead cells turn red.  The fluorescent images of live and dead cells in their 
samples were counted to calculate the cell viability (%) with the following equation: 100 × (number 
of live cells)/(total number of cells).  All experiments were conducted with four repetitions and 
averaged. 
   As shown in Fig 4, the majority of NIH 3T3 and HUVECs were viable even in the presence of 
P1 up to at least 1.0 mg/mL. This clearly demonstrates that amphiphilic/fluorous random 
copolymers, in spite of their perfluorinated pendants, are non-cytotoxic to NIH 3T3 and HUVECs.  
The high biocompatibility could be attributed to the multi-chain association and self-folding 
structures of P1 in aqueous media where the perfluorinated segments are effectively confined 
within the inner spaces covered by PEG chains.  Additionally, the potential biocompatibility of 




Figure 4.  Live/Dead staining of (a, b) NIH 3T3 and (d, e) HUVECs in the presence of P1 ([P1]0 
= 0.1 (a, d), 1.0 (b, e) mg/mL).  Quantification of viability of (c) NIH 3T3 and (f) HUVECs in the 




   Given the non-cytotoxic properties of P1, protein-polymer conjugation was investigated with 
amphiphilic/fluorous random copolymers bearing functional α-ends (pyridyl disulfide: P2; 
N-hydroxysuccinimide ester: P3) and hen egg white lysozyme (Lyz) as a protein.  For the 
conjugation of P2 via disulfide linkages, thiolated lysozyme (Lyz-SH) was prepared by the 
treatment of Lyz with N-succinimidyl-S-acethylthiopropionate (SATP) to form a 
thioacetate-bearing Lyz through amide bonds and deprotection with hydroxyl amine to reveal the 
thiol.11  After the removal of excess SATP, free thiol content incorporated in the resultant Lyz-SH 
was estimated as 4 thiol units per a protein with Ellman’s assay.  Lyz-SH was then treated with P2 
in PBS (pH = 7.4) at 4 oC ([Lyz-SH]0 = 0.22 mg/mL, [P2] = 40.8 mg/mL, P2/Lyz-SH = 50 eq/1 eq) 
to induce formation of P2-ss-Lyz.  Confirmed by DLS, P2 still maintained a large aggregation 
structure in PBS solution.  After 24 h, the mixture was analyzed with sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) (Fig 5).  To visibly identify the successful 
conjugation, Lyz unit was stained by coomassie blue (lane 2, 3). 
 
 
Figure 5. SDS-PAGE visualized by coomassie blue staining (lane 1: protein marker; lane 2: 
Lyz-SH; lane 3: Lyz; lane 4: P2-ss-Lyz; lane 5: P3-Lyz; lane 6: none; lane 7: Lyz-SH with DTT; 
lane 8: P2-ss-Lyz with DTT; lane 9: P2; lane 10: P3). 
 
 
   As seen in lane 4, the conjugation product only exhibited a band with high molecular weight 
(~250 kD) without another small molecular weight band derived from free Lyz-SH (between 10 – 
15 kD), demonstrating that all Lyz-SH was successfully conjugated to P2 to form P2-ss-Lyz.  
Under the SDS-PAGE conditions, P2-ss-Lyz should still maintain the original aggregate structure 
  
because the aggregates are formed with fluorous interaction that is not reversed with water and 
ionic compounds.47  Lyz would be mainly bound onto the surface of the aggregates.  In the 
presence of D,L-dithiothreitol (DTT), the conjugate in turn showed a small molecular weight band 
consistent with Lyz-SH (lane 8).  This is because the disulfide linkage in the conjugate was 
cleaved via reduction with DTT to give P2 and free Lyz-SH therefrom.  However, there was also a 
band still visible in high molecular weight region (~250 kD) after reduction.  Owing to 
hydrophobicity of the perfluorinated core, P2 large aggregate is partially stained in itself (Lane 9 
for P2 and Lane 10 for P3), so what is observed is cleaved polymer aggregates.  Additionally, it is 
quite possible that the large aggregate structure of the polymer protected some of the disulfide 
bonds from cleavage during the short incubation time of the experiment.  This has been observed 
previously for nanogels.15 
   Conjugation of Lyz to P3 was similarly examined and the product was analyzed by SDS-PAGE.  
In contrast to P2 via disulfide linkages, P3 was not as effective for Lyz conjugation via amide bond 
formation: free Lyz was still observed in the product (lane 5).  The lower efficiency for P3-Lyz 
conjugate would be attributed to the steric hindrance around the N-hydroxysuccinimide ester (NHS) 
that is directly connected to the polymer terminal without any spacer.11 It is also possible that some 
of the NHS group was lost during the purification process due to hydrolysis of the end group.  
   Together these data supports the successful conjugation for P2 to Lyz via disulfide bond 
formation.  It also shows that RAFT polymerization was successful in forming 
amphiphilic/fluorous copolymers that contain a pyridyl disulfide group.  The polymers with 
perfluorinated components and PEG side chains formed aggregates in solution that were nontoxic to 
a both a mouse and human cell line.  Thus, the conjugates demonstrated herein could be useful for 
a variety of unique biomedical applications.  For example, perfluorinated compound emulsions are 
often utilized as oxygen carriers.38-40 Thus, these conjugates may be useful for applications where 




   In conclusion, we successfully developed biocompatible and amphiphilic/fluorous random 
copolymers with poly(ethylene glycol) chains and perfluorinated pendants via RAFT 
copolymerization with functional CTAs for protein conjugation.  In water, their copolymers 
intermolecularly associated with multi-chains to form large aggregates that effectively place the 
perfluorinated pendants into the inner fluorous compartment.  Owing to the confined structures in 
water and the potential biocompatibility of the perfluorinated segments, the amphiphilic/fluorous 
random copolymers are non-cytotoxic against NIH 3T3 and HUVECs.  Additionally, thiolated 
  
lysozyme was successfully conjugated onto the large aggregate of an amphiphilic/fluorous random 
copolymer bearing a pyridyl disulfide at -end via a cleavable disulfide linkage.  Such 
protein-polymer conjugate would serve as unique therapeutic materials by using the fluorous 
compartments.  Thus, the PEGylated and perfluorinated copolymers reported herein open new 
vistas in biocompatible materials and biochemical and biomedical applications.  
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  Figure S1.  1H NMR spectra of P2 and (b) P3 in acetone-d6 S2 
  Figure S2.  19F NMR spectra of P2 and (b) P3 in acetone-d6 S3 


























Figure S3.  UV-Vis spectra of P1 (black) and P1 after the transformation of the terminal 
trithiocarbonate group with AIBN (red): [P1]0 = 10 mg/mL in H2O at 25 oC. 
 
 
 
